Episcleritis: Difference between revisions

No edit summary
Line 19: Line 19:
* Must distinguish from [[scleritis]]
* Must distinguish from [[scleritis]]
** Phenylephrine drops lead to transient resolution of episcleral redness permitting evaluation of the sclera
** Phenylephrine drops lead to transient resolution of episcleral redness permitting evaluation of the sclera
* Must distinguish from conjunctivitis
* Must distinguish from [[conjunctivitis]]
** If the conjunctival injection is localized rather than diffuse, episcleritis is more likely
** If the conjunctival injection is localized rather than diffuse, episcleritis is more likely



Revision as of 23:52, 30 July 2011

Background

  • Abrupt onset of inflammation in the episclera
  • 70% of cases occurs in women (usually young and middle-aged)
  • Usually a benign, self-limited condition
  • Usually not associated with an underlying disease

Diagnosis

  • History
    • Abrupt onset of redness, irritation, and watering of the eye
    • Pain is unusual
    • Vision unaffected
    • 50% of cases are bilateral
  • Physical
    • Vasodilatation of the superficial episcleral vessels
    • Focal area(s) of redness
    • May have a tender scleral nodule (nodular episcleritis)

Work-Up

  • Must distinguish from scleritis
    • Phenylephrine drops lead to transient resolution of episcleral redness permitting evaluation of the sclera
  • Must distinguish from conjunctivitis
    • If the conjunctival injection is localized rather than diffuse, episcleritis is more likely

DDx

  1. Scleritis
  2. Conjunctivitis
  3. Herpes Keratitis

Treatment

  1. Topical lubricants
    1. Artificial tears q4-6hr
  2. Oral NSAIDs

Disposition

Refer to ophtho to reduce chance of misdiagnosis

Prognosis

Self-limiting (will resolve within 2-3 weeks)

See Also

Scleritis

Source

UpToDate